|
ARNT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.853650E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.560400E-01 |
| Normal-vs-Stage2 |
8.915600E-02 |
| Normal-vs-Stage3 |
5.994500E-04 |
| Normal-vs-Stage4 |
1.181450E-04 |
| Stage1-vs-Stage2 |
2.684200E-01 |
| Stage1-vs-Stage3 |
2.042000E-03 |
| Stage1-vs-Stage4 |
4.040400E-04 |
| Stage2-vs-Stage3 |
3.800200E-01 |
| Stage2-vs-Stage4 |
1.778810E-01 |
| Stage3-vs-Stage4 |
4.742800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.572100E-02 |
| Normal-vs-AfricanAmerican |
3.323900E-03 |
| Normal-vs-Asian |
3.090600E-01 |
| Caucasian-vs-AfricanAmerican |
2.144200E-01 |
| Caucasian-vs-Asian |
8.880000E-02 |
| AfricanAmerican-vs-Asian |
2.208100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.878500E-03 |
| Normal-vs-Female |
1.354180E-01 |
| Male-vs-Female |
5.657500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.689780E-01 |
| Normal-vs-Age(41-60Yrs) |
8.968500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.923100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.964300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.137400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.135000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.914400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.485800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.758200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.855200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.072100E-02 |
| Normal-vs-Grade 2 |
4.696800E-01 |
| Normal-vs-Grade 3 |
3.084200E-03 |
| Normal-vs-Grade 4 |
5.66159999992877E-07 |
| Grade 1-vs-Grade 2 |
2.744200E-02 |
| Grade 1-vs-Grade 3 |
8.979900E-04 |
| Grade 1-vs-Grade 4 |
6.24789999958963E-07 |
| Grade 2-vs-Grade 3 |
2.116800E-03 |
| Grade 2-vs-Grade 4 |
2.10069999950768E-07 |
| Grade 3-vs-Grade 4 |
8.678500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.828200E-01 |
| Normal-vs-ccB subtype |
5.54200000000282E-05 |
| ccA subtype-vs-ccB subtype |
5.43729505864121E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.944400E-02 |
| Normal-vs-N1 |
2.592600E-01 |
| N0-vs-N1 |
9.572800E-01 |
|
|
